Sichenzia Ross Ference LLP Represents Zynex, Inc. in $60 Million 144A Private Offering of Convertible Notes

Press Release – New York, NY – May 11, 2023 – Sichenzia Ross Ference LLP announced today that it represented Zynex, Inc., (“The Company”) (NASDAQ: “ZYXI”) an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, in a Rule 144A private offering. The offering consisted of the sale of $52.5 million and the sale of a $7.5 million over-allotment of 5.00% Convertible Senior Notes due 2026. 

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Jay Yamamoto, Marcelle Balcombe, Glenn Burlingame, and associates Christian Lichtenberger and Rohini Sud.